Literature DB >> 9230188

Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells.

Q M Wang1, X Luo, G P Studzinski.   

Abstract

Control of cell proliferation remains of intense interest in cancer research. In the 1,25-dihydroxyvitamin D3 HL60 cell system, G1 arrest has been shown to be mediated by elevated levels of p27/Kip1 protein. We show here that the main target of the elevated p27/Kip1 in this system is cyclin-dependent kinase (Cdk) 6. The activity of Cdk2 is also down-regulated, and this is associated with altered and reduced levels of cyclin E in the kinase complex. Paradoxically, the kinase activity of Cdk4 is elevated, in spite of an almost complete G1 block. These data show that the functions of Cdk4 and Cdk6 are not redundant and that Cdk6 and Cdk2 activities are regulated by 1,25-dihydroxyvitamin D3.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230188

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  p21(WAF1) is associated with CDK2 and CDK4 protein during HL-60 cell differentiation by TPA treatment.

Authors:  J W Cho; Y W Jeong; K S Kim; J Y Oh; J C Park; J C Lee; W K Baek; S I Suh; M H Suh
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

2.  Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.

Authors:  Robert Wieder; Steven C Novick; Bruce W Hollis; Margarette Bryan; Suzanne M Chanel; Kate Owusu; Danielle Camastra; Tracie Saunders; Lillian Pliner; Jonathan Harrison; Peter Bonate; Tom Williams; Steven Soignet
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

3.  Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy.

Authors:  Ean-Jeong Seo; Thomas Efferth
Journal:  Oncotarget       Date:  2016-03-29

4.  miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.

Authors:  Shu Lu; Ming-Shan Wang; Pei-Jie Chen; Qiang Ren; Peiming Bai
Journal:  Exp Ther Med       Date:  2017-04-26       Impact factor: 2.447

Review 5.  Policing Cancer: Vitamin D Arrests the Cell Cycle.

Authors:  Sachin Bhoora; Rivak Punchoo
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.